London grandmother may have to move to Scotland to access vital cancer drug unavailable on NHS in England

A London grandmother, Beverley Angell, who has battled breast cancer for over a decade, faces the difficult decision of moving to Scotland to access a pioneering drug, Enhurtu, only available on the NHS there. Despite the drug costing £8,000 per session privately, Beverley, with stage 4 breast cancer, is left with no choice but to uproot her life for a chance at survival, even though it means leaving behind her family and grandchildren. The unfair postcode lottery has pushed Beverley to make a life-changing decision for her health, highlighting the challenges faced by patients in accessing vital treatments.

Full Article